Clinical trial
Phase III Study of Usefulness of Near Infrared Spectroscopy to Optimize Tissues Perfusion and Oxygenation in Severe Sepsis
NCT00167596 is registered in ClinicalTrials.gov with University of Versailles as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase III Study of Usefulness of Near Infrared Spectroscopy to Optimize Tissues Perfusion and Oxygenation in Severe Sepsis
- Lead sponsor
- University of Versailles
- Phase
- Phase 2/3
- Overall status
- Terminated
- Start date
- July 31, 2005
- Completion date
- December 31, 2009
- Enrollment
- 103 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.
critical illness, severe sepsis